CClinicalTrials.gg
TerminatedNCT01602276Updated Dec 20, 2018

The Effect of tDCS on Subcortical Brain Functioning

An interventional study of Transcranial Direct Current Stimulation (tDCS) in Brain Damage, Chronic, sponsored by Johns Hopkins University. Terminated at 1 site in United States. Open to participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-20.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Why this study was terminated
Difficulty identifying appropriate patients

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Feb 2012, registered May 2012).
Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain abilities related to cognition, emotion and/or physical functioning in individuals with subcortical brain damage.

Read the detailed description

While cortical brain structures are thought to be responsible for higher level cognitive functioning (i.e., perception, thoughts, language, memory, attention, and processing), subcortical brain regions (i.e., amygdala, midbrain, hippocampus, and thalamus) are generally believed to be responsible for more fundamental bases of such functions. A significant fraction of the population suffer from disabling disorders and diseases (i.e., Parkinson's disease, subcortical dementia, hypoxic brain damage) that affect subcortical areas. Despite their prevalence, very little success has been achieved in treating such impairments effectively.

This study has two main goals. One is to examine the effect of stimulation on a variety of subcortical functions (i.e., level of alertness, mood, cognition, and motor responding). A second goal is to examine the effects of varying some of the stimulus parameters of tDCS, notably the placement of the electrodes and the duration and frequency of application of current.

Adult participants with a confirmed diagnosis of subcortical brain damage, as well as healthy adults will be randomly assigned to anodal and cathodal stimulation in a counterbalanced order, and both will engage in simple behavioral tasks and/or physiological monitoring. These tasks will be specific to the deficit of interest.

02

Conditions studied

  • Brain Damage, Chronic

Browse trials for

Keywords

  • Parkinson's disease
  • Lewy body dementia
  • Korsakoff's syndrome
  • Subcortical Dementia
  • Huntington's Disease
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 3 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Fluent in the English language
  • History of subcortical brain damage (patient group only)
  • No known neurological or cognitive impairment (control group only)

Exclusion criteria

Exclusion Criteria:

  • Appreciable deficits in hearing
  • Schizophrenia, bipolar disorder, or major depression (normal controls only)
  • Any neurological disorder associated with cognitive impairment or neuroanatomic abnormality (normal controls only)
  • Language-based learning disorder (normal controls only)
  • Dementia or Mini-Mental State Exam \<24 for normal control participants
  • Any implanted metal device (precludes use of tDCS)
  • Any implanted cardiac pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Active Stimulation

    Transcranial direct current stimulation using Anodal or Cathodal stimulation over the area of interest

    Procedure: Transcranial Direct Current Stimulation (tDCS)

  • Sham comparator
    Sham Stimulation

    Transcranial direct current stimulation (tDCS) that is ramped up and ramped down providing the sensation of tDCS without delivering the full amount of tDCS.

    Procedure: Transcranial Direct Current Stimulation (tDCS)

Interventions

  • ProcedureTranscranial Direct Current Stimulation (tDCS)

    Anodal, Cathodal or Sham tDCS

06

What researchers measure

Primary outcomes

  1. Improvement in motor functioning

    Time frame: 1 month

  2. Improvement in level of consciousness and alertness

    Time frame: 1 month

  3. Improvement in cognitive functioning

    Time frame: 1 month

07

Study locations

1 site
  • Department of Neurology; Cognitive Neurology/Neuropsychology
    Baltimore, Maryland 21231, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01602276
Lead sponsor
Johns Hopkins University
Responsible party
Sponsor
First posted
May 18, 2012
Start date
Feb 2012
Primary completion
Oct 9, 2018
Completion
Oct 10, 2018
Last update
Dec 20, 2018

Study contacts

Barry Gordon, M.D., Ph.D.
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion